Collectionner le produit
Détails du produit
- ItemsSize 2mgSize 10mg (5mg × 2)Particle size2 μm2 μmPhysical appearancePowder mixturePowder mixtureSourceGln 25 - Arg 358 & Ser 359 - His 559 (Accession # P51654-1)Gln 25 - Arg 358 & Ser 359 - His 559 (Accession # P51654-1)Amount of Coupled Protein>310 pmol (20 μg) Glypican 3/mg beads>310 pmol (20 μg) Glypican 3/mg beadsFormulationPBS, pH7.4, with 10% TrehalosePBS, pH7.4, with 10% TrehaloseReconstitution2 mL sterile deionized water (1 mg beads/mL)5 mL sterile deionized water (1 mg beads/mL)
Product Description
The Human Glypican 3-coupled Magnetic Beads is produced by coupling biotinylated human Glypican 3 protein to streptavidin-conjugated magnetic beads. The pre-coupled beads are ready to use for capturing anti-Glypican 3 antibody from your sample with high specificity. The uniform size and large surface-to-volume ratio of the beads ensure highly efficent immunocapture in a simple, fast and convenient workflow with high reproducibilty of data.
Application
The beads is intended for immunocapture, biopanning. This is a non-sterile product.
* The Isotype control (Cat. No. SMB-B01) is sold separately.
Storage
This product is stable in storage under the following conditions: -20℃ for 24 months in lyophilized state.
Please avoid more than 3 freeze-thaw cycles once reconstitution, immediate use after reconstitution is highly recommended.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
Typical Data
Immobilized over 20 μg Biotinylated Human Glypican 3 protein on 1 mg Beads can bind the Anti-GPC3 Antibody with an EC50 of 0.1846 μg/mL (QC tested).
Protocol
Avis des utilisateurs Publier un commentaire
Progrès de frontière
Progrès du développement médicamenteux- Nom anglais：
Glypican-3
- Catégorie：
- Nombre de médicaments répertoriés：
0 Détails
- Nombre de médicaments cliniques：
57 Détails
- Étape de développement la plus élevée：
Phase 2 Clinical
Contact Us
Drug Candidate Licensing
